Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy

Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy ( Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy )
22 Oct 2018

KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma

Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale Cancer Center, New Haven, USA )
22 Oct 2018

ESMO 2018: Highlights

Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018

The TRIBE-2 study for colorectal cancer

Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
The TRIBE-2 study for colorectal cancer ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
22 Oct 2018

Advances in metastatic non small cell lung cancer

Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Advances in metastatic non small cell lung cancer ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
21 Oct 2018

Comment on the JAVELIN study: RCC immunotherapy

Prof John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands
Comment on the JAVELIN study: RCC immunotherapy ( Prof John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Oct 2018

Use of T-VEC in early metastatic melanoma

Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands
Use of T-VEC in early metastatic melanoma ( Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Oct 2018

KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC

Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC ( Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA )
21 Oct 2018

Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma

Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma ( Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA )
21 Oct 2018

Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma

Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma ( Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Oct 2018

The past, present and future of treating ovarian cancer

Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The past, present and future of treating ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
21 Oct 2018

Olaparib improves progression free survival up front in ovarian cancer

Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
Olaparib improves progression free survival up front in ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
21 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation